Beijing Strong Biotechnologies,Inc. (SHE:300406)
China · Delayed Price · Currency is CNY 13.26
+0.10 (0.76%)
Feb 4, 2026, 3:04 PM CST
SHE:300406 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 431.71 | 532.64 | 523.74 | 389.1 | 405.65 | 112.28 |
Depreciation & Amortization | 70.24 | 70.24 | 56.21 | 54.82 | 43.62 | 30.21 |
Other Amortization | 1.93 | 1.93 | 0.96 | 0.88 | 1.87 | 1.52 |
Loss (Gain) From Sale of Assets | 2.11 | 2.11 | 3.5 | 2.68 | -0.16 | -1.03 |
Asset Writedown & Restructuring Costs | 1.38 | 1.38 | 0.21 | 5.32 | 0.11 | 2.04 |
Loss (Gain) From Sale of Investments | -9.61 | -9.61 | -20.76 | -19.08 | -11.53 | -1.21 |
Provision & Write-off of Bad Debts | 3.39 | 3.39 | 23.44 | 39.15 | 37.13 | 37.19 |
Other Operating Activities | 172.53 | 48.04 | 52.17 | 60.23 | 83.8 | 17.56 |
Change in Accounts Receivable | 15.81 | 15.81 | -69.02 | -84.94 | -184.23 | -34 |
Change in Inventory | -16.2 | -16.2 | -13.21 | -11.24 | -31.01 | -65.04 |
Change in Accounts Payable | -31.88 | -31.88 | 37.36 | -33.21 | 8.5 | 16.37 |
Operating Cash Flow | 637.57 | 614.01 | 585.09 | 396.17 | 341.1 | 123.06 |
Operating Cash Flow Growth | 2.60% | 4.94% | 47.69% | 16.14% | 177.18% | -34.75% |
Capital Expenditures | -38.76 | -67.65 | -148.03 | -96.48 | -65.2 | -17.25 |
Sale of Property, Plant & Equipment | -0.09 | 0.21 | 1.03 | - | 0.23 | 0.34 |
Cash Acquisitions | - | - | - | -1.44 | - | -1,092 |
Investment in Securities | -379.39 | -73.28 | 15 | -341.28 | -1,256 | 32 |
Other Investing Activities | 111.97 | 122.1 | 4.79 | -1.63 | 8.9 | 1.12 |
Investing Cash Flow | -306.27 | -18.62 | -127.21 | -440.82 | -1,312 | -1,076 |
Long-Term Debt Issued | - | 23.2 | 106.59 | 1,290 | 1,122 | 459.07 |
Long-Term Debt Repaid | - | -33.48 | -104.44 | -1,154 | -302.34 | -243.29 |
Net Debt Issued (Repaid) | -142.79 | -10.28 | 2.15 | 136.16 | 819.94 | 215.78 |
Issuance of Common Stock | 3.21 | 3.21 | 37.09 | - | 37.33 | 1,181 |
Repurchase of Common Stock | -44.66 | -44.66 | -49.45 | -51.1 | - | - |
Common Dividends Paid | -420.75 | -124.19 | -64.66 | -90.65 | -78.61 | -82.44 |
Other Financing Activities | 22.79 | -0.55 | 0.12 | -4.99 | -1.98 | -9.47 |
Financing Cash Flow | -582.2 | -176.48 | -74.76 | -10.58 | 776.67 | 1,305 |
Foreign Exchange Rate Adjustments | 0.15 | 0.52 | 0.2 | 1.03 | -0.36 | -0.38 |
Net Cash Flow | -250.74 | 419.43 | 383.32 | -54.21 | -194.67 | 351.52 |
Free Cash Flow | 598.81 | 546.36 | 437.06 | 299.69 | 275.9 | 105.81 |
Free Cash Flow Growth | 14.38% | 25.01% | 45.84% | 8.63% | 160.74% | -16.81% |
Free Cash Flow Margin | 41.78% | 32.93% | 25.09% | 19.84% | 17.25% | 12.48% |
Free Cash Flow Per Share | 1.01 | 0.92 | 0.73 | 0.49 | 0.47 | 0.19 |
Cash Income Tax Paid | 192.66 | 197.19 | 189.57 | 162.92 | 165.81 | 90.29 |
Levered Free Cash Flow | 161.83 | 338 | 293.07 | 157.06 | 211.82 | -89.55 |
Unlevered Free Cash Flow | 192.05 | 367.75 | 322.44 | 189.96 | 225.32 | -84.45 |
Change in Working Capital | -36.1 | -36.1 | -54.37 | -136.93 | -219.38 | -75.49 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.